Stocktoria
Canopy Growth Corp CGC
Canopy Growth Corp (CGC) earns a Piotroski F-score of 4/9 (mixed financial health). It does not currently pay a dividend. FY2026 revenue was $346.8M at a -75.8% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -3.47 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| CGC | Canopy Growth Corp | 4/9 | — | — | +10.5% |
| JUSHF | Jushi Holdings Inc. | 3/9 | -4.96 | — | +2.1% |
| CRON | Cronos Group Inc. | 6/9 | — | — | +19.5% |
| AAWH | Ascend Wellness Holdings, Inc. | 4/9 | -1.32 | — | -10.9% |
| BTMD | biote Corp. | 5/9 | 0.92 | 2.5 | -2.5% |
| GLAS | Glass House Brands Inc. | 3/9 | -1.45 | — | -9.4% |
| MRMD | MARIMED INC. | 4/9 | -1.76 | — | +1.3% |
About Canopy Growth Corp
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel. It also provides vaporizers and accessories; dried flower and pre-rolled joints, oil, and vapes and beverages; extracts and concentrates, such as softgel capsules; and cannabis edibles, including gummies. In addition, the company operates e-commerce shop; medical cannabis online distribution platform; and an online medical cannabis clinic. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Abba Medix, Storz & Bickel, Wana, and Claybourne, Apollo, Canada House, R'belle, LowKey, MTL Cannabis, DeeLish, DOJA brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
FAQ
Is CGC financially healthy?
Canopy Growth Corp's Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak).
Does CGC pay a dividend?
No, Canopy Growth Corp does not currently pay a dividend.
How profitable is CGC?
In FY2026, Canopy Growth Corp had a net margin of -75.8% and a return on equity of -37.7%.
What is the analyst price target for CGC?
The average Wall-Street price target for Canopy Growth Corp is $1.22, about 19.2% above the recent price, from 1 analysts (consensus: hold).
Is CGC a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Canopy Growth Corp: a Piotroski F-score of 4/9. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2026-03-31. Facts plus Stocktoria's own computed scores — not investment advice.